KRISTIN MICKELSON: Open Payments
NPI 1982072682 · UPLAND, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$807 in 36 payments from 15 companies in 2025. Trend: 2023 $774 · 2024 $446 · 2025 $807
Food & beverage: $807
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 5 | $145 |
| PFIZER INC. | 7 | $135 |
| ABBVIE INC. | 6 | $97 |
| Arcutis Biotherapeutics, Inc. | 3 | $69 |
| Lilly USA, LLC | 2 | $55 |
| Novartis Pharmaceuticals Corporation | 2 | $42 |
| Regeneron Healthcare Solutions, Inc. | 1 | $42 |
| Galderma Laboratories, L.P. | 1 | $36 |
| Amgen Inc. | 2 | $35 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $34 |
Products named: Bimzelx, CIBINQO, Zoryve, TALTZ, RINVOQ, SKYRIZI, LITFULO, DUPIXENT.
Industry payments across CA — which companies pay providers there.
